Sign in
4

Changes in Ownership

BIOLARGO, INC. Filed Acc 0001437749-20-014604

Options or other derivatives

  • Chief Financial Officer acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
DARGAN CHARLES K Chief Financial Officer 2020-06-30 Grant or award · Option to purchase common stock +5,000 3,633,286 D: show line 1 in the form
Loading xslF345X03/rdgdoc.xml…